Loading...
OTC Markets
Totals
Securities
12,234
Dollar Vol
$2.2B
Share Vol
4B
Trades
348,417

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

KBLB
Kraig Biocraft Laboratories, Inc.

Common Stock

0.0825

-0.0053

-6.04%

0.0825 / 0.084 (51298 x 111681)

Real-Time Best Bid & Ask: 05:00pm 07/25/2025
Delayed (15 Min) Trade Data: 12:00am 07/25/2025
OTC Disclosure & News Service

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, is very happy to announce today that the Company has officially initiated commercial production scale up of its recombinant spider silk production at its Vietnamese subsidiary, Prodigy Textiles. During a trip this week Jon Rice, the Company’s chief operating officer, successfully delivered the Company’s specialized silkworm eggs to the production team, at Prodigy Textiles’ recently renovated factory. This moment marks a pivotal milestone in the commercialization and production of eco-friendly and cost effective recombinant spider silk.

“The significance of today’s announcement can’t be overstated. By clearing this critical production hurdle, we are now aggressively ramping up to produce and fill demand for our recombinant spider silk materials,” said Rice. “Having demonstrated our materials’ performance capabilities and secured necessary approvals, we are now focused on the exciting next phase of our business model; delivering our high performance silk yarns to the market and formalizing strategic partnerships. Our dream of a sustainable and cost effective method to produce recombinant spider silk is now in operation.”

With capacity scale up now officially underway in Vietnam, the Company is focused on the production of its recombinant spider silk threads and yarns for delivery to collaborative partners and target market segments.

The Company has been working with senior officials in Vietnam for several years to secure the necessary permits and approvals needed to bring its revolutionary spider silk technology to production. The delivery of these progenitor silkworms into the Company’s Vietnamese facility marks the success of that process and the beginning of a new era in performance textiles.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward-looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

OTCQB Venture Market Logo
Joined OTCQB 03/2015
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.